MRI QSM Imaging for Iron Overload
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04631718|
Recruitment Status : Recruiting
First Posted : November 17, 2020
Last Update Posted : March 23, 2023
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
The overall goal of this project is to develop and validate a novel technique for Magnetic Resonance Imaging (MRI)-based Quantitative Susceptibility Mapping (QSM) of the abdomen, for non-invasive assessment of liver iron deposition. In this work, study team will develop and optimize advanced data acquisition and image reconstruction methods to enable QSM of the abdomen. Further, investigators will determine the accuracy, repeatability, and reproducibility of abdominal QSM for iron quantification in patients with liver iron overload.
Excessive accumulation of iron in various organs, including the liver, which affects both adult and pediatric populations, is toxic and requires treatment aimed at reducing body iron stores. Accurate assessment of liver iron concentration is critical for the detection and staging of iron overload as well as for longitudinal monitoring during treatment.
In summary, this project will develop a novel MRI-based QSM technique designed for the abdomen and will validate it in pediatric and adult patients with liver iron overload. Upon successful validation, QSM will provide accurate, repeatable, and reproducible quantification of LIC based on a fundamental property of tissue.
|Condition or disease||Intervention/treatment|
|Hemochromatosis Iron Overload||Radiation: Magnetic Resonance Imaging (MRI)-based Quantitative Susceptibility Mapping (QSM)|
|Study Type :||Observational|
|Estimated Enrollment :||80 participants|
|Official Title:||MRI-based Quantitative Susceptibility Mapping of Hepatic Iron Overload|
|Actual Study Start Date :||January 18, 2022|
|Estimated Primary Completion Date :||March 2024|
|Estimated Study Completion Date :||March 2025|
MRI based abdominal QSM
Participants with known or suspected iron overload with past serum ferritin >500 will be recruited in this study.
Radiation: Magnetic Resonance Imaging (MRI)-based Quantitative Susceptibility Mapping (QSM)
MRI-based QSM methods estimate the susceptibility of tissues based on measuring the magnetic field distortion produced by the tissues themselves.
Upon successful validation, MRI-based abdominal QSM will provide accurate, repeatable, and reproducible quantification of Liver iron concentration (LIC) that is independent of the distribution of iron and does not require calibration.
- Establishing the accuracy of MRI-QSM of the liver using SQUID-BLS as a reference [ Time Frame: 1.5 hours ]Determine the accuracy of abdominal QSM to quantify liver iron concentration at 1.5T and 3T, in pediatric and adult patients with liver iron overload, using superconducting quantum interference device (SQUID)-based biomagnetic liver susceptometry (BLS) as the reference.
- Establishing the repeatability of MRI-QSM of the liver [ Time Frame: up to 1.5 hours ]
Repeatability of MRI-QSM of the liver will be established in both pediatrics and adult participants. Each participant will be scanned at both 1.5T and 3T and at UW will repeat one of the field strengths to assess repeatability. Therefore, each participant at UW will undergo 3 MRI exams and each participant at Stanford 2 MRI exams.
Repeatability will not be tested at Stanford in order to avoid exhaustion of the patients (many of whom will be children), and to ensure the completion of acquisitions at both field strengths for validation of accuracy versus SQUID-BLS. Scanning will take 1.5 hour at University of Wisconsin and I hour at Stanford
- Establishing the reproducibility of MRI-QSM of the liver [ Time Frame: up to 1.5 hours ]
The reproducibility of abdominal MRI-based Quantitative Susceptibility Mapping (MRI-QSM) will be characterized across field strengths (1.5Tesla and 3Tesla), in both pediatric and adult participants with iron overload The repeated acquisitions at 1.5T and 3T will enable analysis of reproducibility of MRI-QSM across field strengths. At UW only, participants repeat either the 1.5T or 3T exam, with consideration given to the subject's schedule and magnet availability. Repeat tests will be performed after removing the participants from the magnet and repositioning with new localizer images. Repeatability will not be tested at Stanford in order to avoid exhaustion of the patients (many of whom will be children), and to ensure the completion of acquisitions at both field strengths for validation of accuracy versus SQUID-BLS.
Scanning will take 1.5 hour at University of Wisconsin and I hour at Stanford
- Optimizing MRI-based QSM performance by using multiple QSM reconstruction and measurement [ Time Frame: up to 1.5 hours ]
Multiple QSM reconstructions will be applied to each acquired dataset, to evaluate the effect of each reconstruction component on the performance of QSM.
Susceptibility measurements will be made by placing a region-of-interest in each of the nine Couinaud segments of the liver. This will allow segment-by-segment analysis as well as whole-liver analysis (by averaging over the 9 segments) of the performance of QSM. The reader performing MRI analysis will be blinded to SQUID results.
Scanning will take 1.5 hour at University of Wisconsin and I hour at Stanford.
- MRI-QSM data acquisition with Breath held [ Time Frame: 1.5 hours ]An optimized acquisition will obtain 3D whole liver coverage within a ~20 second breath-hold. Data will be collected at 1.5T and 3T
- MRI-QSM data acquisition with Free Breathing [ Time Frame: 1.5 hours ]The optimized free-breathing acquisitions (using bellows, butterfly navigators, and 2D sequential acquisitions and requiring 3-5 min each) will be performed. Data will be collected at 1.5T and 3T
- Comparison of MRI-based QSM of the liver to serum ferritin measurements [ Time Frame: up to 3.5 hours ]MRI-based QSM of the liver will be compared to serum ferritin measurements to validate MRI-QSM method. MRI-QSM visit will be scheduled within +/-2 days of serum ferritin measurement visit
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||5 Years and older (Child, Adult, Older Adult)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||No|
|Sampling Method:||Non-Probability Sample|
- Ages 10 years or older at University of Wisconsin - Madison
- Age 5 years or older at Stanford
- Known or suspected iron overload
- Patients with contraindication to MRI (e.g. pacemaker, contraindicated metallic implants, claustrophobia, etc)
- Pregnant or trying to become pregnant (as determined by self-report during MRI safety screening)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04631718
|Contact: Study Coordinator||(608) 807-9594||Radstudy@uwhealth.org|
|United States, California|
|School of Medicine, Stanford University||Not yet recruiting|
|Stanford, California, United States, 94305|
|Contact: Shreyas Vasanawala, MD, PhD 650-723-8087 email@example.com|
|Principal Investigator: Shreyas Vasanawala|
|United States, Wisconsin|
|University of Wisconsin||Recruiting|
|Madison, Wisconsin, United States, 53705|
|Contact: Study Coordinator 608-807-9594 Radstudy@uwhealth.org|
|Principal Investigator:||Diego Hernando, PhD||University of Wisconsin, Madison|
|Responsible Party:||University of Wisconsin, Madison|
|Other Study ID Numbers:||
1R01DK117354-01 ( U.S. NIH Grant/Contract )
A539300 ( Other Identifier: UW Madison )
SMPH/RADIOLOGY/RADIOLOGY ( Other Identifier: UW Madison )
Protocol Version 9/10/2021 ( Other Identifier: UW Madison )
|First Posted:||November 17, 2020 Key Record Dates|
|Last Update Posted:||March 23, 2023|
|Last Verified:||March 2023|
|Individual Participant Data (IPD) Sharing Statement:|
|Plan to Share IPD:||No|
|Studies a U.S. FDA-regulated Drug Product:||No|
|Studies a U.S. FDA-regulated Device Product:||Yes|
|Device Product Not Approved or Cleared by U.S. FDA:||Yes|
|Product Manufactured in and Exported from the U.S.:||No|
Liver iron concentration
Magnetic Resonance Imaging (MRI)-based Quantitative Susceptibility Mapping (QSM)
Iron Metabolism Disorders
Metal Metabolism, Inborn Errors
Metabolism, Inborn Errors
Genetic Diseases, Inborn